Elanco Animal Health

General Information


Founded in 1954 as part of Eli Lilly and Company, Elanco is a premier animal health company that innovates, develops, manufactures and markets products for companion and food animals. Headquartered in Greenfield, Indiana, we are the fourth largest animal health company in the world, with revenue of $2.9 billion for the year ended December 31, 2017. Globally, we are #1 in medicinal feed additives, #2 in poultry and #3 in cattle, measured by 2017 revenue, according to Vetnosis. We also have one of the broadest portfolios of pet parasiticides in the companion animal sector. We offer a diverse portfolio of more than 125 brands that make us a trusted partner to veterinarians and food animal producers in more than 90 countries.

Employees: 5880
Founded: 1954
Contact Information
Address 2500 Innovation Way, Greenfield, IN 46140, US
Phone Number (877) 352-6261
Web Address http://www.elanco.com
View Prospectus: Elanco Animal Health
Financial Information
Market Cap $8548.6mil
Revenues $2957.8 mil (last 12 months)
Net Income $-172.3 mil (last 12 months)
IPO Profile
Symbol ELAN
Exchange NYSE
Shares (millions): 62.9
Price range $24.00 - $24.00
Est. $ Volume $1509.6 mil
Manager / Joint Managers Goldman Sachs/ J.P. Morgan/ Morgan Stanley
CO-Managers Barclays/ BNP PARIBAS/ BofA Merrill Lynch/ Citigroup/ Credit Suisse/ Deutsche Bank Securities/ Evercore ISI/ Cowen/ Academy Securities/ Drexel Hamilton/ Mischler Financial Group/ Ramirez/ The Williams Capital Group
Expected To Trade: 9/20/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change